nintedanib has been researched along with Skin-Neoplasms* in 1 studies
1 trial(s) available for nintedanib and Skin-Neoplasms
Article | Year |
---|---|
Targeting Both Tumor and Stroma Cells to Treat Melanoma: NIPAWILMA.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Paclitaxel; Skin Neoplasms; Stromal Cells; Survival Rate; Treatment Outcome; Young Adult | 2016 |